10x Genomics Stock Crashes. 'Disruptive' Changes Hit Third-Quarter Sales

10x Genomics Stock Crashes. ‘Disruptive’ Changes Hit Third-Quarter Sales

10x Genomics (TXG) stock crashed Thursday after the medtech reported preliminary third-quarter sales that widely missed Street expectations, thanks to a highly “disruptive” reorganization. ↑ X NOW PLAYING How To Sell Stocks: Long-Term Trend Lines The company is a leader in spatial biology, a process that involves understanding where specific cells and tissues are within…

Read More